Purchase Order FA820112P0075
Award Date 7/31/12
Potential Completion Date 9/30/12
Potential Value $98K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Hill AFB, UT 84056, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Brigham & Women's Hospital Inc. received a $4.42 million firm fixed-price contract from the Food and Drug Administration on July 13, 2020, to conduct a study entitled "Risk Evaluation and Mitigation Strategy (REMS) Programs to Promote Appropriate Medication Use and Knowledge." REMS programs are FDA-mandated risk management plans designed to ensure that the benefits of certain medications outweigh their risks by restricting distribution or requiring specific safety measures. The...
- The Food and Drug Administration's Center for Devices and Radiological Health (CDRH) awarded a $134,380.12 firm fixed-price delivery order to Software Information Resource Corp. for nQuery Advanced Software enterprise licensing and maintenance support. This award represents the exercise of Option Period 3 under an existing contract vehicle, extending services through February 14, 2028. The delivery order was issued without a small business set-aside designation and is being performed under the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $4,729.28 and a period of performance ending on June 16, 2025. The contract is a firm fixed-price delivery order, which means the price is predetermined and not subject to adjustment. This award is...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to support military treatment programs and facilities. The contract has a ceiling value of $27,864.94 and is a firm fixed price delivery order contract. It does not have a set-aside...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 1 MG TABLET 30S, with a ceiling value of $3,120.56 and a performance period ending on May 22, 2025. The contract is a Firm Fixed Price (FFP) type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a delivery order awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of REXULTI 2 MG TABLET 30S, a prescription medication. The contract has a ceiling value of $3,928.00 and a completion date of September 27, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This delivery order modification to The Mitre Corporation represents a closeout action by the FDA's Center for Drug Evaluation and Research (CDER) to de-obligate remaining funds under a contract focused on Risk Evaluation and Mitigation Strategy (REMS) prescriber education innovation development. The contract, awarded September 29, 2021, with an ultimate completion date of November 30, 2022, carried a ceiling value of approximately $1.01 million under a Cost Plus Fixed Fee pricing structure. The...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $18,861.53 and a period of performance through July 7, 2025. The contract is a firm fixed-price delivery order, indicating that Amerisourcebergen will provide the specified product at a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 1 MG TABLET 30S, with a ceiling value of $6,307.17 and a performance period through June 17, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 0.25 MG TABLET 30S, with a ceiling value of $1,952.36 and a performance period ending on May 22, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...